Vontobel Holding Ltd. decreased its position in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 69.9% during the third quarter, HoldingsChannel reports. The firm owned 4,427 shares of the electronics maker’s stock after selling 10,281 shares during the period. Vontobel Holding Ltd.’s holdings in Dolby Laboratories were worth $320,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of DLB. MAI Capital Management lifted its position in Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Dolby Laboratories by 590.4% in the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after acquiring an additional 431 shares during the last quarter. Ameritas Advisory Services LLC purchased a new stake in shares of Dolby Laboratories in the 2nd quarter valued at $48,000. Atlantic Union Bankshares Corp purchased a new position in Dolby Laboratories in the 2nd quarter worth $50,000. Finally, Elevation Point Wealth Partners LLC bought a new stake in Dolby Laboratories in the second quarter worth $60,000. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Dolby Laboratories Stock Performance
Shares of Dolby Laboratories stock opened at $65.41 on Wednesday. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66. The stock has a market cap of $6.25 billion, a price-to-earnings ratio of 24.87 and a beta of 0.89. The stock has a 50 day moving average price of $66.35 and a 200-day moving average price of $70.65.
Dolby Laboratories Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is 54.75%.
Analysts Set New Price Targets
Several brokerages recently weighed in on DLB. Barrington Research dropped their target price on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. Robert W. Baird began coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price objective on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Rosenblatt Securities dropped their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $92.00.
Check Out Our Latest Report on DLB
Insider Activity at Dolby Laboratories
In other news, EVP Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $66.73, for a total transaction of $607,843.57. Following the completion of the sale, the executive vice president directly owned 73,054 shares in the company, valued at approximately $4,874,893.42. The trade was a 11.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Yeaman sold 36,699 shares of the stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $66.91, for a total value of $2,455,530.09. Following the sale, the chief executive officer directly owned 114,725 shares in the company, valued at $7,676,249.75. This represents a 24.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 162,120 shares of company stock worth $10,906,559. 37.93% of the stock is owned by company insiders.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
